Gynecologic Oncology Associates is categorized under Oncologists in La Jolla, CA and active since 2001.
Gynecologic Oncology Associates was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Pam Register at the company’s single location by writing to 9850 Genesee Avenue # 570, La Jolla, California CA 92037 or by phoning (858) 455-5524. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Gynecologic Oncology Associates |
Contact Person: | Pam Register |
Address: | 9850 Genesee Avenue # 570, La Jolla, California 92037 |
Phone Number: | (858) 455-5524 |
Website Address: | gynoncology.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Oncologists |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Gynecologic Oncology Associates was started in 2001 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Pam Register for inquiries that concern Gynecologic Oncology Associates by calling the company number (858) 455-5524, as your correspondence is most welcome. Additionally, the physical location of the single location of Gynecologic Oncology Associates can be found at the coordinates 32.883414,-117.221781 as well as the street address 9850 Genesee Avenue # 570 in La Jolla, California 92037.
For its online presence, you may visit Gynecologic Oncology Associates’s website at gynoncology.com and engage with its social media outlets through on Twitter and on Facebook.